{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:54:37Z","timestamp":1793321677245,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.drugalcdep.2020.108272","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T21:33:50Z","timestamp":1599773630000},"page":"108272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Impact of behavioral and medication treatment for alcohol use disorder on changes in HIV-related outcomes among patients with HIV: A longitudinal analysis"],"prefix":"10.1016","volume":"217","author":[{"given":"Kathleen A.","family":"McGinnis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Skanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Jennifer","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Todd","family":"Korthuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Oldfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Wyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Justice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin L.","family":"Kraemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108272_bib0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/aid.2009.0211","article-title":"Alcohol use accelerates HIV disease progression","volume":"26","author":"Baum","year":"2010","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108272_bib0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/jrh.12345","article-title":"Differences in receipt of alcohol\u2010related care across rurality among VA patients living with HIV with unhealthy alcohol use","volume":"35","author":"Bensley","year":"2019","journal-title":"J. Rural Health"},{"issue":"10","key":"10.1016\/j.drugalcdep.2020.108272_bib0015","first-page":"597","article-title":"Implementation of evidence-based alcohol screening in the Veterans Health Administration","volume":"12","author":"Bradley","year":"2006","journal-title":"Am. J. Manag. Care"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108272_bib0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/acer.12975","article-title":"Characterizing the association between alcohol and HIV virologic failure in a military cohort on antiretroviral therapy","volume":"40","author":"Deiss","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108272_bib0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10461-018-2241-z","article-title":"Efficacy of extended-release naltrexone on HIV-related and drinking outcomes among HIV-positive patients: a randomized-controlled trial","volume":"23","author":"Edelman","year":"2019","journal-title":"AIDS Behav."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108272_bib0030","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1016\/S2352-3018(19)30076-1","article-title":"Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trial","volume":"6","author":"Edelman","year":"2019","journal-title":"Lancet HIV"},{"key":"10.1016\/j.drugalcdep.2020.108272_bib0035","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/01.mlr.0000223670.00890.74","article-title":"Development and verification of a virtual cohort using the National VA Health Information System","author":"Fultz","year":"2006","journal-title":"Med. Care"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108272_bib0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.15288\/jsa.2002.63.179","article-title":"The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV cost and services utilization study","volume":"63","author":"Galvan","year":"2002","journal-title":"J. Stud. Alcohol"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108272_bib0045","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/acer.13965","article-title":"Gender differences in use of alcohol treatment services and reasons for nonuse in a national sample","volume":"43","author":"Gilbert","year":"2019","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108272_bib0050","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/jamainternmed.2019.0086","article-title":"A clinical overview of off-label use of gabapentinoid drugs","volume":"179","author":"Goodman","year":"2019","journal-title":"JAMA Intern. Med."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108272_bib0055","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s40263-015-0244-0","article-title":"Topiramate in alcohol use disorders: review and update","volume":"29","author":"Guglielmo","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.drugalcdep.2020.108272_bib0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsat.2015.01.002","article-title":"Examining the specification validity of the HEDIS quality measures for substance use disorders","volume":"53","author":"Harris","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108272_bib0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamainternmed.2017.7856","article-title":"Gabapentinoid use in the United States 2002 through 2015","volume":"178","author":"Johansen","year":"2018","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.108272_bib0070","series-title":"A Stata Plugin for Estimating Group-based Trajectory Models. Research Showcase@ CMU","author":"Jones","year":"2012"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108272_bib0075","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0049124101029003005","article-title":"A SAS procedure based on mixture models for estimating developmental trajectories","volume":"29","author":"Jones","year":"2001","journal-title":"Sociol. Methods Res."},{"key":"10.1016\/j.drugalcdep.2020.108272_bib0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2016.01.017","article-title":"Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men","volume":"161","author":"Justice","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108272_bib0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/QAI.0b013e31826741aa","article-title":"Unhealthy alcohol and illicit drug use are associated with decreased quality of HIV care","volume":"61","author":"Korthuis","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2020.108272_bib0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jsat.2019.05.007","article-title":"Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans","volume":"103","author":"Kraemer","year":"2019","journal-title":"J. Subst. Abuse Treat."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108272_bib0095","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jama.2018.11406","article-title":"Diagnosis and pharmacotherapy of alcohol use disorder: a review","volume":"320","author":"Kranzler","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2020.108272_bib0100","series-title":"VA\/DoD Clinical Practice Guideline for Management of Substance Use Disorders (SUD)","author":"Management of Substance Use Disorders Working Group","year":"2009"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108272_bib0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/ADM.0000000000000443","article-title":"Topiramate pharmacotherapy for alcohol use disorder and other addictions: a narrative review","volume":"13","author":"Manhapra","year":"2019","journal-title":"J. Addict. Med."},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108272_bib0110","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/QAD.0000000000001473","article-title":"Long-term alcohol use patterns and HIV disease severity","volume":"31","author":"Marshall","year":"2017","journal-title":"AIDS (London, England)"},{"issue":"12","key":"10.1016\/j.drugalcdep.2020.108272_bib0115","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/ntr\/ntr206","article-title":"Validating smoking data from the Veteran\u2019s Affairs Health Factors dataset, an electronic data source","volume":"13","author":"McGinnis","year":"2011","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.drugalcdep.2020.108272_bib0120","series-title":"Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: an Updated Systematic Review for the U.S. Preventive Services Task Force","author":"O\u2019Connor","year":"2018"},{"key":"10.1016\/j.drugalcdep.2020.108272_bib0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jsat.2019.11.002","article-title":"Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV","volume":"109","author":"Oldfield","year":"2020","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2020.108272_bib0130","series-title":"Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living With HIV","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","year":"2019"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108272_bib0135","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/QAI.0b013e318158a461","article-title":"Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial","volume":"46","author":"Parsons","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108272_bib0140","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/acer.13953","article-title":"Association between gabapentin receipt for any indication and alcohol use disorders identification test\u2014consumption scores among clinical subpopulations with and without alcohol use disorder","volume":"43","author":"Rentsch","year":"2019","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108272_bib0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/088922204773004860","article-title":"Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire","volume":"20","author":"Samet","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108272_bib0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/135965350501000106","article-title":"A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems","volume":"10","author":"Samet","year":"2005","journal-title":"Antivir. Ther."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108272_bib0155","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/QAI.0b013e318142aabb","article-title":"Alcohol consumption and HIV disease progression","volume":"46","author":"Samet","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108272_bib0160","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/QAD.0000000000002140","article-title":"Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals","volume":"33","author":"Tate","year":"2019","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.drugalcdep.2020.108272_bib0165","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1111\/acer.13204","article-title":"Alcohol use and human immunodeficiency virus (HIV) infection: current knowledge, implications, and future directions","volume":"40","author":"Williams","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2020.108272_bib0170","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.drugalcdep.2017.06.011","article-title":"Variation in receipt of pharmacotherapy for alcohol use disorders across racial\/ethnic groups: a national study in the U.S. Veteran Health Administration","volume":"178","author":"Williams","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108272_bib0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/08897077.2016.1268238","article-title":"Psychosocial stressors and alcohol use, severity, and treatment receipt across human immunodeficiency virus (HIV) status in a nationally representative sample of US residents","volume":"38","author":"Williams","year":"2017","journal-title":"Subst. Abus."},{"key":"10.1016\/j.drugalcdep.2020.108272_bib0180","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.drugalcdep.2017.01.018","article-title":"Among patients with unhealthy alcohol use, those with HIV are less likely than those without to receive evidence-based alcohol-related care: a national VA study","volume":"174","author":"Williams","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108272_bib0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.drugalcdep.2018.04.022","article-title":"Changes in alcohol use associated with changes in HIV disease severity over time: a national longitudinal study in the Veterans Aging Cohort","volume":"189","author":"Williams","year":"2018","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108272_bib0190","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s10461-018-2210-6","article-title":"Level of alcohol use associated with HIV care continuum targets in a national US sample of persons living with HIV receiving healthcare","volume":"23","author":"Williams","year":"2019","journal-title":"AIDS Behav."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620304373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620304373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:09:04Z","timestamp":1759828144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620304373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":38,"alternative-id":["S0376871620304373"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108272","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of behavioral and medication treatment for alcohol use disorder on changes in HIV-related outcomes among patients with HIV: A longitudinal analysis","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108272"}}